María Teresa Herrera

Dr. María Teresa Herrera

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2012 in BMC Immunology
Verified
Journal Article
Open access
PDF file
YHYolanda González Hernández
Yolanda González Hernández
MHMaría Teresa Herrera
María Teresa Herrera
GSGloria Soldevila
Gloria Soldevila
LGLourdes García-García
Lourdes García-García
GFGuadalupe Fabián
Guadalupe Fabián
MTMartha Torres
Martha Torres
Background: CD33 is a membrane receptor containing a lectin domain and a cytoplasmic immunoreceptor tyrosine-based inhibitory motif (ITIM) that is able to inhibit cytokine production. CD33 is expressed by monocytes, and reduced expression of CD33 correlates with augmented production of inflammatory cytokines, such as IL-1β, TNF-α, and IL-8. However, the role of CD33 in the inflammation associated with hyperglycemia and diabetes is unknown. Therefore, we studied CD33 expression and inflammatory cytokine secretion in freshly isolated monocytes from patients with type 2 diabetes. To evaluate the effects of hyperglycemia, monocytes from healthy donors were cultured with different glucose concentrations (15-50 mmol/l D-glucose), and CD33 expression and inflammatory cytokine production were assessed. The expression of suppressor of cytokine signaling protein-3 (SOCS-3) and the generation of reactive oxygen species (ROS) were also evaluated to address the cellular mechanisms involved in the down-regulation of CD33. Results: CD33 expression was significantly decreased in monocytes from patients with type 2 diabetes, and higher levels of TNF-α, IL-8 and IL-12p70 were detected in the plasma of patients compared to healthy donors. Under high glucose conditions, CD33 protein and mRNA expression was significantly decreased, whereas spontaneous TNF-α secretion and SOCS-3 mRNA expression were increased in monocytes from healthy donors. Furthermore, the down-regulation of CD33 and increase in TNF-α production were prevented when monocytes were treated with the antioxidant α-tocopherol and cultured under high glucose conditions. Conclusion: Our results suggest that hyperglycemia down-regulates CD33 expression and triggers the spontaneous secretion of TNF-α by peripheral monocytes. This phenomenon involves the generation of ROS and the up-regulation of SOCS-3. These observations support the importance of blood glucose control for maintaining innate immune function and suggest the participation of CD33 in the inflammatory profile associated with type 2 diabetes.

1 April 1996 in Journal of Laboratory and Clinical Medicine
Verified
Journal Article
Closed access
MDMaria Lilia Diaz
Maria Lilia Diaz
MHMaría Teresa Herrera
María Teresa Herrera
YVYolanda López- Vidal
Yolanda López- Vidal
JCJuan J. Calva
Juan J. Calva
Rogelio Hernández-PandoRogelio Hernández-Pando
Rogelio Hernández-Pando
ESEduardo Sada
Eduardo Sada

25 April 2013 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
PTPEDRO TORRES-GONZALEZ
PEDRO TORRES-GONZALEZ
OSOrbelin Soberanis-Ramos
Orbelin Soberanis-Ramos
AMAreli Martinez-Gamboa
Areli Martinez-Gamboa
BCBarbara Chavez-Mazari
Barbara Chavez-Mazari
MHMaría Teresa Herrera
María Teresa Herrera
MBMiriam Bobadilla-Del-Valle
Miriam Bobadilla-Del-Valle
Human tuberculosis caused by M. bovis is a zoonosis presently considered sporadic in developed countries, but remains a poorly studied problem in low and middle resource countries. The disease in humans is mainly attributed to unpasteurized dairy products consumption. However, transmission due to exposure of humans to infected animals has been also recognized. The prevalence of tuberculosis infection and associated risk factors have been insufficiently characterized among dairy farm workers (DFW) exposed in settings with poor control of bovine tuberculosis. Tuberculin skin test (TST) and Interferon-gamma release assay (IGRA) were administered to 311 dairy farm and abattoir workers and their household contacts linked to a dairy production and livestock facility in Mexico. Sputa of individuals with respiratory symptoms and samples from routine cattle necropsies were cultured for M. bovis and resulting spoligotypes were compared. The overall prevalence of latent tuberculosis infection (LTBI) was 76.2% (95% CI, 71.4–80.9%) by TST and 58.5% (95% CI, 53.0–64.0%) by IGRA. Occupational exposure was associated to TST (OR 2.72; 95% CI, 1.31–5.64) and IGRA (OR 2.38; 95% CI, 1.31–4.30) adjusting for relevant variables. Two subjects were diagnosed with pulmonary tuberculosis, both caused by M. bovis. In one case, the spoligotype was identical to a strain isolated from bovines. We documented a high prevalence of latent and pulmonary TB among workers exposed to cattle infected with M. bovis, and increased risk among those occupationally exposed in non-ventilated spaces. Interspecies transmission is frequent and represents an occupational hazard in this setting. Mycobacterium tuberculosis complex causes tuberculosis in humans and other mammals. The complex includes M. bovis, which causes bovine tuberculosis. The main route of transmission of this zoonosis is the consumption of unpasteurized dairy products. Nevertheless, exposure to infected cattle while performing husbandry and farm activities may cause disease as well. In this study we were able to demonstrate: 1) A high prevalence of tuberculosis asymptomatic infection (latent tuberculosis) among workers exposed to infected cattle; 2) A higher probability of infection among individuals who are occupationally exposed in closed spaces; and 3) Cattle to human transmission confirmed by molecular methods (spoligotyping). We conclude that occupational exposure is frequent, and therefore strict prevention and control measures are required in these settings.

1 August 2003 in Journal of Immunological Methods
Verified
Journal Article
Closed access
RGRobert E.M. Guerkov
Robert E.M. Guerkov
OTOleg S. Targoni
Oleg S. Targoni
CKChristian R. Kreher
Christian R. Kreher
BBBernhard O. Boehm
Bernhard O. Boehm
MHMaría Teresa Herrera
María Teresa Herrera
SSStephan K. Schwander
Stephan K. Schwander

11 July 2018 in Journal of Clinical Immunology
Verified
Journal Article
Closed access
PDF file
JRJérémie Rosain
Jérémie Rosain
COCarmen Oleaga-Quintas
Carmen Oleaga-Quintas
CDCaroline Deswarte
Caroline Deswarte
HVHannah Verdin
Hannah Verdin
SMStéphane Marot
Stéphane Marot
JBJacinta Bustamante
Jacinta Bustamante

1 February 2020 in Microbial Pathogenesis
Verified
Journal Article
Closed access
JVJoel Armando Vázquez-Pérez
Joel Armando Vázquez-Pérez
CCConcepción Ortega Carrillo
Concepción Ortega Carrillo
MIMarco Antonio Iñiguez-García
Marco Antonio Iñiguez-García
IRIvan Romero-Espinoza
Ivan Romero-Espinoza
JMJosé Eduardo Márquez-García
José Eduardo Márquez-García
MHMaría Teresa Herrera
María Teresa Herrera